DoW Peer Reviewed Medical, Impact Award

The fiscal year 2026 Peer Reviewed Medical Research Program (PRMRP) Impact Award supports applied research that brings together outcomes from basic research and insights from the real-world environment to foster clinical applicability. The award intends to translate the fundamental understanding of underlying mechanisms toward solutions that have the potential for major near-term impact for patients. The funding mechanism allows for multiple Principal Investigators (PIs) and expects to allot roughly $32.0M to fund approximately 10 Impact Award applications. Key features of this opportunity include: • The maximum period of performance is 4 years • Total cost caps of $2.8M for the Single PI Option, or $3.6M for the Partnering PI Option • The award is open to any type of entity, subject to any clarification in the text field entitled "Additional Information on Eligibility" • The opportunity is listed as a Discretionary funding opportunity